|
TM9SF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59655999999453E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.811300E-04 |
| Normal-vs-Stage2 |
2.343800E-03 |
| Normal-vs-Stage3 |
4.89240000001168E-06 |
| Normal-vs-Stage4 |
3.87390000000654E-06 |
| Stage1-vs-Stage2 |
8.511200E-01 |
| Stage1-vs-Stage3 |
1.988550E-01 |
| Stage1-vs-Stage4 |
1.051750E-01 |
| Stage2-vs-Stage3 |
4.771800E-01 |
| Stage2-vs-Stage4 |
2.419400E-01 |
| Stage3-vs-Stage4 |
5.265600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.3302999999929E-06 |
| Normal-vs-AfricanAmerican |
7.944100E-02 |
| Normal-vs-Asian |
2.766000E-04 |
| Caucasian-vs-AfricanAmerican |
2.185800E-01 |
| Caucasian-vs-Asian |
8.624600E-01 |
| AfricanAmerican-vs-Asian |
2.160400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81489999995232E-06 |
| Normal-vs-Female |
6.45449999999714E-05 |
| Male-vs-Female |
2.360000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.776900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.80729999998963E-06 |
| Normal-vs-Age(61-80Yrs) |
2.001200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.942400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.736440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.435400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.315800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.809200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.227000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.680000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.567020E-01 |
| Classical-VS-Follicular |
5.302800E-01 |
| Classical-VS-Other |
2.223400E-01 |
| Classical-VS-Normal |
1.795340E-04 |
| Tall-VS-Follicular |
3.218600E-01 |
| Tall-VS-Other |
5.761400E-01 |
| Tall-VS-Normal |
1.763930E-04 |
| Follicular-VS-Other |
3.766400E-01 |
| Follicular-VS-Normal |
7.962800E-04 |
| Other-VS-Normal |
9.962000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6420000000037E-05 |
| Normal-vs-N1 |
2.57869999997773E-06 |
| N0-vs-N1 |
1.916410E-01 |
|
|
